LGG-27. TARGETED THERAPY FOR PEDIATRIC LOW-GRADE GLIOMAS AND PLEXIFORM NEUROFIBROMAS WITH TRAMETINIB

BACKGROUND: Targeted therapy aimed at modulating the RAS/RAF/MEK/ERK pathway is of increasing interest for patients with plexiform neurofibromas and low-grade gliomas. Trametinib is an FDA-approved MEK inhibitor that has little published pediatric experience to date. METHODS: A retrospective chart r...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Neuro Oncol
Hoofdauteurs: Nguyen, Tiffany, McMahon, Kathleen, Hemenway, Molly, Levy, Jean Mulcahy, Foreman, Nicholas, Dorris, Kathleen
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Oxford University Press 2020
Onderwerpen:
Low Grade Glioma
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7715454/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa222.409
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items